The field of invention is a new inhibitory peptide containing a segment which inhibits the activation of MyD88. The invention comprises the inhibitory peptide and its application for treatment of disease states connected with excessive activation of the innate immune response.
F.09 Development of a new technological process or technology
COBISS.SI-ID: 4380954Lecture at the University of Osaka, in the most succesfull research group in immunology in the world.
B.04 Guest lecture
COBISS.SI-ID: 4905498The doctoral work of Dr.. Monika Avbelj explored the role of intermediate and N-terminal domain adapter MyD88.
F.02 Acquisition of new scientific knowledge
COBISS.SI-ID: 259787520